9.97
Korro Bio Inc Borsa (KRRO) Ultime notizie
Citi Initiates Korro Bio(KRRO.US) With Buy Rating, Announces Target Price $21 - Moomoo
Citigroup Initiates Korro Bio at Buy With $21 Price Target - marketscreener.com
Lynx1 Capital Management LP's Korro Bio Inc(KRRO) Holding History - GuruFocus
Should You Sell Korro Bio (KRRO) After -8.12% Drop? 2026-05-15Cash Flow - newser.com
Korro Bio, Inc. advances KRRO-121 RNA editing therapy for hyperammonemia toward clinical stage - Traders Union
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
New Korro Bio hire gets option for 3,000 shares at $11.20 - Stock Titan
Korro Bio, Inc.Common Stock (NQ: KRRO - The Chronicle-Journal
Korro Bio (KRRO) Price Target Decreased by 30.76% to 66.30 - MSN
Korro announces oversubscribed $85 million private placement - MSN
Number of shareholders of Korro Bio, Inc. – NASDAQ:KRRO - TradingView
Korro Bio (NASDAQ:KRRO) Announces Quarterly Earnings Results - MarketBeat
Wave Life Sciences (WVE) Attracts Positive Attention Amid Compet - GuruFocus
JonesTrading Upgrades Korro Bio(KRRO.US) to Buy Rating, Announces Target Price $23 - Moomoo
Jones Trading upgrades Korro Bio stock rating on AATD program potential By Investing.com - Investing.com South Africa
Jones Trading upgrades Korro Bio stock rating on AATD program potential - Investing.com Nigeria
Chardan Capital Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Korro Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Korro Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Korro Bio IncReports No Collaboration Reve - Moomoo
Korro Bio (KRRO) trims R&D spend and boosts cash to $157M - Stock Titan
Korro Bio, Inc. 1Q 2026: Revenue $0M, EPS $(1.69) — 10-Q Summary - TradingView
Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Korro raises $85M, targets 2026 filing for rare-disease drug - Stock Titan
Korro Bio (Nasdaq: KRRO) boosts cash to $157M and targets 2026 KRRO-121 filing - Stock Titan
What Korro Bio (KRRO) management is not saying enough about (Technical Strength) 2026-05-06Top Trending Breakouts - newser.com
Korro CEO and top executives line up two investor fireside chats - Stock Titan
Korro to Participate in Upcoming Investor Conferences - marketscreener.com
Korro Bio Inc expected to post a loss of $1.84 a shareEarnings Preview - TradingView
What makes Korro Bio, Inc. (KRRO) a new buy stock - MSN
What Makes Korro Bio, Inc. (KRRO) a New Buy Stock - Yahoo Finance Australia
Raymond James upgrades Korro Bio (KRRO) - MSN
Korro Bio (KRRO) Moat Analysis | Q4 2025: Earnings Beat EstimatesExpert Momentum Signals - Cổng thông tin điện tử tỉnh Lào Cai
KRRO (Korro Bio Inc.) reports smaller than projected Q4 2025 loss, shares rise nearly 7 percent on investor optimism.Hot Market Picks - newser.com
Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences - The Manila Times
Korro brings ammonia and liver disease data to 4 spring conferences - Stock Titan
[ARS] Korro Bio, Inc. SEC Filing - Stock Titan
Korro Bio (KRRO) outlines 2026 virtual meeting, director elections and pay vote - Stock Titan
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule - National Today
Latest KRRO NewsKorro to Present at the 42nd Annual J.P. Mo... - Stock Titan
Korro Bio reports inducement grant under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - TradingView
New Korro Bio hire gets stock option for 15,000 shares under Nasdaq rule - Stock Titan
Block Trades: Does Korro Bio Inc have pricing powerWeekly Investment Summary & Reliable Breakout Forecasts - baoquankhu1.vn
Lynx1 Capital Management LP Increases Stake in Korro Bio Inc - GuruFocus
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):